Evaluation of Lupus Cases Related to TNF Inhibitors in Children
Systemic lupus erythematosus (SLE) due to anti-tumor necrosis factor (TNF) agents is a rare entity. We reported three cases who developed lupus-like syndrome while receiving infliximab therapy for various reasons. All cases demonstrated clinical and laboratory findings of SLE. And all of them needed...
Saved in:
Main Authors: | Şeyma Türkmen (Author), Nelgin Gerenli (Author), Betül Sözeri (Author) |
---|---|
Format: | Book |
Published: |
Galenos Publishing House,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is There Any Effect of Diagnostic Disease Activity Index on Current Myocardial Function in Pediatric Inflammatory Bowel Disease Patients?
by: Esra Polat, et al.
Published: (2022) -
Anti-TNF-α and hydralazine drug-induced lupus
by: Maria Victória Quaresma, et al.
Published: (2015) -
Thalidomide-based inhibitor for TNF-α: designing and Insilico evaluation
by: Biradar Shivaleela, et al.
Published: (2022) -
Editorial
by: Betül Sözeri
Published: (2021) -
Comparative Evaluation of the Treatment Efficacy and Safety of TNFα and IL12/23 Inhibitors in Children With Psoriasis
by: Nikolay N. Murashkin, et al.
Published: (2019)